ArticleFrontiers in pediatrics2026
Effect of iron supplementation on brain myelination and neurodevelopmental outcomes in children aged 0-3 years: a systematic review protocol.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Iron deficiency is one of the most prevalent micronutrient deficiencies globally, affecting nearly 40% of children aged 6-59 months. Iron plays an essential role in early brain development, particularly in myelination, neurotransmitter synthesis and energy metabolism. Deficiency during critical developmental periods may impair cognitive, motor and behavioral outcomes. Although iron supplementation improves hematological parameters, its effects on brain myelination and neurodevelopmental outcomes in children aged 0-3 years remain unclear. Objective: To evaluate the effects of iron supplementation administered during pregnancy or early childhood (0-3 years) on brain myelination and neurodevelopmental outcomes in children. Methods: This systematic review protocol follows PRISMA 2020 and Cochrane Handbook recommendations and has been prospectively designed for registration in PROSPERO. We will search PubMed, EMbase, Scopus, CENTRAL, PsycINFO, CINAHL and Web of Science for randomized controlled trials, quasi-experimental studies, cohort studies, and observational studies evaluating iron supplementation in pregnant women or children aged 0-3 years. Interventions will include iron supplementation in any form and dosage, compared with placebo, standard care, or alternative interventions. Primary outcomes include cognitive, motor, language, executive function, memory and myelination outcomes assessed through validated neurodevelopmental tools and neuroimaging modalities. Secondary outcomes include adverse events. Risk of bias will be assessed using ROB 2 and ROBINS-I tools and certainty of evidence will be evaluated using the GRADE approach. Discussion: This review will synthesize current evidence regarding the role of iron supplementation in brain myelination and neurodevelopment during early childhood. The findings may inform clinical practice and public health policy, particularly in low- and middle-income settings where iron deficiency is highly prevalent. Clinical Trial Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261388359, Registration ID: CRD420261388359.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.